Bristol-Myers Squibb Company (BMY)
NYSE: BMY · Real-Time Price · USD
63.83
-0.82 (-1.27%)
At close: Aug 14, 2026, 4:00 PM EDT
63.66
-0.17 (-0.27%)
Pre-market: Aug 17, 2026, 6:18 AM EDT

BMY Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
49,18648,19448,30045,00646,15946,385
Revenue Growth
3.11%-0.22%7.32%-2.50%-0.49%9.10%
Cost of Revenue
13,93913,19411,94910,62910,1379,940
Gross Profit
35,24735,00036,35134,37736,02236,445
Selling, General & Admin
7,3157,1527,8657,6787,7777,655
Research & Development
9,7679,4929,7829,2879,50910,195
Amortization of Goodwill & Intangibles
2,5313,3178,8729,0479,59510,023
Operating Expenses
19,61319,96126,51926,01226,88127,873
Operating Income
15,63415,0399,8328,3659,1418,572
Interest Expense
-1,723-1,892-1,958-1,161-1,205-1,303
Interest & Investment Income
51458647844917139
Earnings From Equity Investments
1784744-38-108231
Currency Exchange Gain (Loss)
17923116014832
Other Non Operating Income (Expenses)
1,4152,1241,4812,1191,8271,708
EBT Excluding Unusual Items
16,03515,9969,9089,8949,9749,279
Merger & Restructuring Charges
-531-1,089-1,968-809-520-724
Gain (Loss) on Sale of Investments
450233-28-122-693514
Gain (Loss) on Sale of Assets
108-1-15-2119
Asset Writedown
-1,479-949-2,819---
Legal Settlements
-183-434-84-10-178-82
Other Unusual Items
-371-707-400-266261
Pretax Income
11,9099,328-8,3798,4407,7138,098
Income Tax Expense
2,6342,2725544001,3681,084
Earnings From Continuing Operations
9,2757,056-8,9338,0406,3457,014
Minority Interest in Earnings
7-2-15-15-18-20
Net Income
9,2827,054-8,9488,0256,3276,994
Net Income to Common
9,2827,054-8,9488,0256,3276,994
Net Income Growth
83.84%--26.84%-9.54%-
Shares Outstanding (Basic)
2,0382,0342,0272,0692,1302,221
Shares Outstanding (Diluted)
2,0442,0392,0272,0782,1462,245
Shares Change
0.47%0.59%-2.45%-3.17%-4.41%-0.58%
EPS (Basic)
4.563.47-4.413.882.973.15
EPS (Diluted)
4.543.46-4.413.862.953.12
EPS Growth
82.74%--30.85%-5.45%-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
11,44012,84513,94212,65111,94815,234
Free Cash Flow Per Share
5.606.306.886.095.576.79
Dividend Per Share
2.5102.4902.4202.3102.1902.010
Dividend Growth
2.03%2.89%4.76%5.48%8.96%9.24%
Gross Margin
71.66%72.62%75.26%76.38%78.04%78.57%
Operating Margin
31.79%31.20%20.36%18.59%19.80%18.48%
Profit Margin
18.87%14.64%-18.53%17.83%13.71%15.08%
Free Cash Flow Margin
23.26%26.65%28.87%28.11%25.88%32.84%
EBITDA
18,93019,11619,40718,13419,42319,329
EBITDA Margin
38.49%39.66%40.18%40.29%42.08%41.67%
D&A For EBITDA
3,2964,0779,5759,76910,28210,757
EBIT
15,63415,0399,8328,3659,1418,572
EBIT Margin
31.79%31.20%20.36%18.59%19.80%18.48%
Effective Tax Rate
22.12%24.36%-4.74%17.74%13.39%
Revenue as Reported
49,18648,19448,30045,00646,15946,385
Advertising Expenses
----1,3001,300
SEC Filings: 10-K · 10-Q